期刊
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
卷 10, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fcell.2022.1068952
关键词
CHK; CSK; Src; protein tyrosine kinase; oncogene; cancer
资金
- NTU University
- Hunan Province BRJH Foundation
- [NTU03083068]
- [HNBRJH2015ZSD]
This article summarizes the important roles of Src family kinases (SFKs) in multiple signaling pathways, with a focus on the inhibitory function of CHK in tumor development and its regulation of various substrates. Although the precise functions of CHK are still unclear, it has been found to allosterically inhibit Src kinase activity and is regulated through promoter methylation.
Src family kinases (SFKs) play pivotal roles in multiple signaling pathways (Yeatman, 2004). SFK activity is inhibited by phosphorylation at its C-terminal tyrosine, by CSK (C-terminal Src kinase) and CHK (CSK-homologous kinase). CHK expression is restricted to normal hematopoietic cells, brain, and colon tissues. Downregulation of CHK in brain and colon tumors contributes to tumorigenicity in these tissues. CHK does not phosphorylate Src efficiently, however, in contrast to CSK, CHK inhibits Src kinase activity allosterically. Although the functions of CHK are still largely unknown, potential substrates of CHK including beta-synuclein, alpha-tubulin, alpha-spectrin, 14-3-3, and Hsp90 have been identified. CHK is regulated epigenetically via promoter methylation. As the unknown roles of CHK are beginning to be revealed, current knowledge of regulation, molecular targets and functions of CHK is summarized, and important topics for future CHK research are discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据